Baltimore, D. Intracellular immunization. Nature 335, 395–397 (1988).
Vanden Driessche, T., Chuah, M.K.L., Chang, H.-K. Ensoli, B. & Morgan, R.A. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4 T lymphocytes by retroviral vectors expressing anti-HIV genes. J. Virol. 69, 40–45 (1995).
Trono, D., Feinberg, M.B. & Baltimore, D. HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59, 113–120 (1989).
Woffendin, C., Rangs, U., Yang, Z.-Y. Xu, L. & Nabel, G.J. Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc. Natl. Acad. Sci. USA 93, 2889–2894 (1996).
Morgan, R.A. & Walker, R. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein to syn-geneic lymphocytes in HIV-1 infected identical twins. Hum. Gene Then 7, 1281–1306 (1996).
Ensoli, B., Barillari, G., Salahuddin, S.Z., Gallo, R.C. & Wong-Stall, F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 344, 84–86 (1990).
Banda, N.K. et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp Med. 176, 1099–1106 (1992).
Gardner, M.B., Endres, M. & Barry, P. The simian retroviruses: SIV and SRV. in The Retroviridae. The Viruses, Vol. 3 (ed. Levy, J.A.) 133–276 (Plenum Press, New York, 1994).
Kindt, T.J., Hirsch, V.M., Johnson, P.R. & Sawasdikosol, S. Animal models for acquired immunodeficiency syndrome. Adv. Immunol. 52, 425–474 (1992).
Bunnell, B.A., Metzger, M., Byrne, E., Morgan, R.A. & Donahue, R.E. Efficient in vivo marking of primary CD4 T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. Blood 89, 1987–1995 (1997).
Endres, C.L., Bergquam, E.P., Axthelm, M.K. & Wong, S.W. Suppression of simian immunodeficiency virus replication by human immunodeficiency virus type 1 trans-dominant negative rev mutants. J. Virol. 69, 5164–516 (1995).
Bunnell, B.A., Muul, L.M., Donahue, R.E., Blaese, R.M. & Morgan, R.A. High-efficiency retroviral mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 92, 7739–7743 (1995).
Siekevitz, M. et al. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science 238, 1575–1578 (1992).
Levine, B.L. et al. Antiviral effect and ex vivo CD4 T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272, 1939–1943 (1996).
Lohman, B.L. et al. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68, 7021–7029 (1994).
Kestler, H.W. et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651–662 (1991).
Haigwood, H.L. et al. Passive immune globulin therapy in the SIV/macaque model: Early intervention of immunodeficiency and immunosuppression. Immunol. Lett. 51, 107–114 (1996).
Pantaleo, G. How immune-based interventions can change HIV therapy. Nature Med. 3, 483–486 (1997).
Donahue, R.E. et al. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87, 1644–1653 (1996).
Clements, J.E. et al. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69, 2737–2744 (1995).
Mankowski, J.L. et al. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J. Virol. 68, 8202–8208 (1994).
Laird, N.M. & Ware, J.H. Random-effects models for longitudinal data. Biometrics 38, 963–974 (1982).